RNPL
Renol Polychem financials
- Market cap
- ₹79 Cr
- Sector
- Chemicals
Quarterly results
| Line item | Q2 FY25 | Q4 FY25 | Q2 FY26 | Q4 FY26 |
|---|---|---|---|---|
| Revenue | 29 | 33 | 40 | 49 |
| EBITDA | 3 | 4 | 3 | 8 |
| Net profit | 2 | 3 | 2 | 6 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −12.6% 1Y
1Y: ₹70.75 on 10 Sept 2025 → ₹61.85. High ₹154 (23 Jan 2026), low ₹61.85 (11 Sept 2026).
Balance sheet
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Equity capital | ₹5 Cr | ₹8 Cr | ₹12 Cr |
| Reserves | ₹3 Cr | ₹31 Cr | ₹96 Cr |
| Borrowings | ₹3 Cr | ₹0 Cr | ₹1 Cr |
| Other liabilities | ₹4 Cr | ₹5 Cr | ₹7 Cr |
| Total liabilities | ₹15 Cr | ₹44 Cr | ₹116 Cr |
| Fixed assets | ₹0 Cr | ₹2 Cr | ₹16 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹37 Cr |
| Other assets | ₹15 Cr | ₹42 Cr | ₹63 Cr |
| Total assets | ₹15 Cr | ₹44 Cr | ₹116 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Mar 2026
Since Sep 2025, the public added +22.31 pp while promoters trimmed −18.00 pp. The shareholder count grew 5% to 599.
- Promoters
- 51.1%
- Public
- 48.9%
Since Sep 2025
- Public +22.31 pp
- Promoters −18.00 pp
- DIIs −3.63 pp
Who bought this quarter
since Sep 2025
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Hetalben Bhaveshbhai Harsoda +4.97 pp 4.97% held
- Le Merite Exports Limited newly disclosed 1.64% held
- Civitas Equifin Llp newly disclosed 1.49% held
- Vishai Exim Private Limited newly disclosed 1.44% held
- Chiragkumar Bharatbhai Patel newly disclosed 1.39% held
- L7 Hitech Private Limited newly disclosed 1.30% held
The same filing shows 2 holders trimming and 3 off the list — both are in the register beside this.
Who is on the register
Named in the Mar 2026 filing
Every holder of Renol Polychem Ltd above SEBI's 1% disclosure line, and what changed since Sep 2025.
| Holder | Stake | Change |
|---|---|---|
| Bhavesh Mansukhbhai Harsoda | 33.88% | −17.65 pp |
| Naitik Bhaveshbhai Harsoda | 12.26% | −5.31 pp |
| Hetalben Bhaveshbhai Harsoda | 4.97% | +4.97 pp |
| Le Merite Exports Limited | 1.64% | newly disclosed |
| Civitas Equifin Llp | 1.49% | newly disclosed |
| Vishai Exim Private Limited | 1.44% | newly disclosed |
| Chiragkumar Bharatbhai Patel | 1.39% | newly disclosed |
| L7 Hitech Private Limited | 1.30% | newly disclosed |
| Labhuben Mansukhbhai Harsoda | 0.00% | unchanged |
| Generational Capital Breakout Fund 1 AIF | — | off the list |
| Persistent Growth Fund- Varsu India Growth Story Scheme-1 Mutual fund | — | off the list |
| Compact Structure Fund AIF | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
- Growth the price implies
- -10.7% a year
- for 7 years, fading to 4%
- It has actually compounded at
- Not enough history
- The gap
- —
- between what it did and what it must do
Learn to analyse Renol Polychem Ltd
Guides on how to read this kind of business and the numbers that matter.